Pharmacy UGM – In celebration of its 78th anniversary, the Faculty of Pharmacy at Universitas Gadjah Mada (UGM) successfully organized The 6th APN Annual Workshop and Symposium 2024 in collaboration with the Asian Pharmacometrics Network (APN). This event, held from November 20-22, 2024, featured various speakers from diverse backgrounds, including researchers, lecturers, practitioners, and students from across Asia.
With the theme “Pharmacometrics in the Optimization of Drug Development and Clinical Therapy,” this event aimed to optimize drug development and clinical therapy. During the event, workshops, scientific presentations, and panel discussions were conducted, featuring keynote speakers from prominent experts in the field.
“The Faculty of Pharmacy UGM realized and is enthusiastic to organize this important event in 2024 in collaboration with the Asian Pharmacometrics Network, and we believe that the event is one of the strategic ways to support further development in pharmaceutical sciences, especially the role of pharmacometrics interrupt development and clinical therapy,” said Prof. Dr. Apt. Akhmad Kharis Nugroho, M.Si., as the event coordinator and representing the Dean of the Faculty of Pharmacy UGM in his opening speech.
In addition to contributing to the advancement of pharmaceutical science, this event also supports the achievement of the Sustainable Development Goals (SDGs), especially in the areas of Good Health and Well-Being (SDG 3) and Industry, Innovation, and Infrastructure (SDG 9). Through a data-driven approach presented in this workshop, pharmacometrics can contribute to the development of more targeted therapies, which in turn will improve healthcare quality, reduce inequities in access to medicines, and enhance the effectiveness of treatments.
Furthermore, the event emphasized the importance of international collaboration (SDG 17) in addressing global health challenges. By inviting experts from various countries, the Faculty of Pharmacy UGM strengthens its role in facilitating discussions and collaborations that can accelerate breakthroughs in pharmaceutical research and medical innovations. (Rara/HumasFA)
SDGs 3, 9, and 17